Published in J Gen Virol on December 01, 1985
An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol (1991) 12.00
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs. Nucleic Acids Res (1987) 2.22
Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1991) 1.79
Polyprotein processing of Theiler's murine encephalomyelitis virus. J Virol (1989) 1.64
Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus. Nucleic Acids Res (1987) 1.62
The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J Virol (1995) 1.61
Effect of mutations downstream of the internal ribosome entry site on initiation of poliovirus protein synthesis. J Virol (1994) 1.28
The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J Virol (2011) 1.25
Influence of Theiler's murine encephalomyelitis virus 5' untranslated region on translation and neurovirulence. J Virol (1992) 1.13
Functional analysis of the two alternative translation initiation sites of foot-and-mouth disease virus. J Virol (1995) 1.07
Bovine rhinitis viruses are common in U.S. cattle with bovine respiratory disease. PLoS One (2015) 1.01
Internal ribosomal entry site-mediated translation initiation in equine rhinitis A virus: similarities to and differences from that of foot-and-mouth disease virus. J Virol (2000) 0.88
The major form of hepatitis C virus alternate reading frame protein is suppressed by core protein expression. Nucleic Acids Res (2008) 0.86
Multifunctional roles of leader protein of foot-and-mouth disease viruses in suppressing host antiviral responses. Vet Res (2015) 0.78
Biological function of Foot-and-mouth disease virus non-structural proteins and non-coding elements. Virol J (2016) 0.75
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (1982) 5.50
Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature (1987) 5.26
Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J (1995) 4.44
The atomic structure of the bluetongue virus core. Nature (1998) 4.27
Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus. J Virol (1979) 3.54
The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol (1989) 3.53
Propranolol as ocular hypotensive agent. Br J Ophthalmol (1967) 3.42
Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology (1976) 3.20
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology (1999) 3.00
The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus. Nucleic Acids Res (1984) 3.00
Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug. Br J Clin Pharmacol (1976) 2.99
Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. Virology (1984) 2.60
Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature (1984) 2.52
Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon. RNA (1996) 2.45
3'-Terminal nucleotide sequences in the genome RNA of picornaviruses. Nature (1978) 2.40
Protein covalently linked to foot-and-mouth disease virus RNA. Nature (1977) 2.35
Location of the initiation site for protein synthesis on foot-and-mouth disease virus RNA by in vitro translation of defined fragments of the RNA. J Virol (1980) 2.34
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol (1992) 2.27
Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotypes 1 and 4. Virology (1987) 2.27
All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs. Nucleic Acids Res (1987) 2.22
A physico-chemical sub-grouping of the mammalian picornaviruses. J Gen Virol (1973) 2.08
A re-appraisal of the biochemical map of foot-and-mouth disease virus RNA. J Gen Virol (1978) 2.06
Safety and efficacy of chymopapain (Chymodiactin) in herniated nucleus pulposus with sciatica. Results of a randomized, double-blind study. JAMA (1983) 2.06
The replication of picornaviruses. J Gen Virol (1979) 2.03
Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature (1987) 2.00
Sequence and location of the poly C tract in aphtho- and cardiovirus RNA. Nucleic Acids Res (1979) 1.95
The highly ordered double-stranded RNA genome of bluetongue virus revealed by crystallography. Cell (1999) 1.84
The nucleotide sequence of cDNA coding for the structural proteins of foot-and-mouth disease virus. Gene (1982) 1.82
A new and improved method for 3'-end labelling DNA using [alpha-32P]ddATP. Gene (1984) 1.78
Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J Gen Virol (1994) 1.77
Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes. Nature (1981) 1.73
Diazoxide in treatment of primary pulmonary hypertension. Br Heart J (1978) 1.71
A steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain. J Biol Chem (1996) 1.71
More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA. J Virol (1978) 1.69
Presence of a covalently linked protein on calicivirus RNA. J Gen Virol (1978) 1.66
Comparison of the amino acid sequence of the major immunogen from three serotypes of foot and mouth disease virus. Nucleic Acids Res (1982) 1.66
Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus. Nucleic Acids Res (1987) 1.62
Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature (1987) 1.57
Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat. Diabetologia (1989) 1.57
Heterogeneity of the genome-linked protein of foot-and-mouth disease virus. J Virol (1980) 1.50
Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology (1995) 1.50
Beta-sympathetic blockade in hyperthyroidism. Lancet (1966) 1.49
Sequences of vesicular stomatitis virus RNA in the region coding for leader RNA, N protein mRNA, and their junction. Proc Natl Acad Sci U S A (1979) 1.48
Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites In vivo. Mol Cell Biol (2000) 1.47
Haemodynamic changes during methohexitone anaesthesia in patients with supraventricular arrhythmias. Br J Anaesth (1967) 1.45
Use of UV irradiation to identify the genetic information of vesicular stomatitis virus responsible for shutting off cellular RNA synthesis. J Virol (1979) 1.44
Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement. Eur Respir J (2007) 1.43
Translocation portals for the substrates and products of a viral transcription complex: the bluetongue virus core. EMBO J (2001) 1.35
The sequence of foot-and-mouth disease virus RNA to the 5' side of the poly(C) tract. Gene (1985) 1.31
Enhanced infectivity of modified bluetongue virus particles for two insect cell lines and for two Culicoides vector species. Virology (1996) 1.28
Complete sequence characterization of the genome of the St Croix River virus, a new orbivirus isolated from cells of Ixodes scapularis. J Gen Virol (2001) 1.28
Buoyant density of picornaviruses in caesium salts. J Gen Virol (1971) 1.28
A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus. J Gen Virol (1975) 1.27
Host cell selection of antigenic variants of foot-and-mouth disease virus. J Gen Virol (1989) 1.26
Surface structure of foot-and-mouth disease virus. J Gen Virol (1969) 1.25
Differential precipitation of foot and mouth disease virus proteins made in vivo and in vitro by hyperimmune and virus particle guinea pig antisera. Virology (1981) 1.24
A serogroup specific enzyme-linked immunosorbent assay for the detection and identification of African horse sickness viruses. J Virol Methods (1991) 1.23
A model for vesicular exanthema virus, the prototype of the calicivirus group. J Gen Virol (1978) 1.22
Further evidence for multiple proteins in the foot-and-mouth disease virus particle. J Gen Virol (1971) 1.22
Inhibition of transcription by immunoglobulins directed against the ribonucleoprotein of homotypic and heterotypic vesicular stomatitis viruses. J Virol (1978) 1.22
Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses. J Gen Virol (1979) 1.22
Biochemical mapping of the foot-and-mouth disease virus genome. J Gen Virol (1977) 1.21
Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype. Virology (1989) 1.20
Bunyamwera virus replication in cultured Aedes albopictus (mosquito) cells: establishment of a persistent viral infection. J Virol (1981) 1.20
Encephalomyocarditis virus antibodies in sera from apparently normal pigs. Vet Rec (1977) 1.19
Sequence of the hemagglutinin gene of influenza virus A/Memphis/1/71 and previously uncharacterized monoclonal antibody-derived variants. Virology (1983) 1.19
Multiple proteases in foot-and-mouth disease virus replication. J Virol (1984) 1.18
Immunological priming with synthetic peptides of foot-and-mouth disease virus. J Gen Virol (1985) 1.18
A comparison of six different bluetongue virus isolates by cross-hybridization of the dsRNA genome segments. Virology (1987) 1.18